Skip to content
Open access

Olfactory dysfunction, subjective perception, and cognition in Parkinson’s disease

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor features such as bradykinesia, resting tremor, and rigidity. However, non-motor symptoms are now recognized as an integral component of the disease. Hyposmia is present in more than 90% of patients at diagnosis, and may precede motor symptoms, potentially serving as an early marker of PD. Despite its prevalence, olfactory dysfunction is often not reported by patients. Olfaction can be assessed by different tests, such as the Sniffin’ Sticks (SS-12) and the modified Connecticut Chemosensory Clinical Research Center (mCCCRC) test, the latter derived from a recently validated in the Brazilian population and showing good performance in PD patients. Objective: To evaluate the relationship between subjective perception of hyposmia, objective olfactory performance, and cognitive function in patients with PD and controls using two olfactory tests. Methods: A transversal case-control study was conducted at a university outpatient neurology clinic. PD group: patients diagnosed by a movement disorders specialist, ≤85 years, disease duration ≥2 years, without dementia. Controls: individuals without neurodegenerative disease aged 60–85 years. Cognitive function was assessed with Montreal Cognitive Assessment (MoCA). A questionnaire collected clinical data and hyposmia complaints. Exclusion criteria included head trauma, rhinosinusitis, and nasal surgery. Olfaction was assessed using SS-12 and mCCCRC. Mann–Whitney and chi-square tests were used (p<0.05). Results: 106 individuals (53 PD, 53 controls) were evaluated, with similar demographic features. Among participants classified with hyposmia, 96.6% of controls and 30.3% of PD patients denied smell impairment. A significant association was observed between subjective perception of hyposmia and objective olfactory disfunction (p<0.05). Cognitive performance was lower in PD group (17.1±6.2 vs 21.3±4.0; p=0.003). Both olfactory tests were worse in PD than in controls (p<0.0001) and had moderate correlation (rho=0.65; p<0.0001). Participants reporting hyposmia showed significantly lower scores in both mCCCRC (p<0.001) and SS-12 (p<0.001), as well as lower cognitive performance (p=0.035). MoCA scores were positively associated with SS-12 performance in both groups (PD: p<0.001; controls: p=0.012), and this association remained significant in controls after adjustment for age, smoking, and education (p=0.04). For the mCCCRC test, this relationship was observed only in the PD group (p=0.021). Conclusion: Subjective perception of hyposmia shows poor agreement with olfactory disfunction in PD, with many patients failing to recognize smell dysfunction. Cognitive performance influences olfactory identification, particularly in SS-12, while mCCCRC appears less cognitively dependent, supporting the need for objective assessment over self-report.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.